SG Americas Securities Boosts Stake in Cabot Corporation

Institutional investor increases position in specialty chemicals company by 260% in Q4 2025

Apr. 5, 2026 at 8:43am

Got story updates? Submit your updates here. ›

SG Americas Securities LLC, an institutional investor, significantly increased its stake in Cabot Corporation (NYSE: CBT) by 260% in the fourth quarter of 2025, according to a recent SEC filing. The firm now owns 36,301 shares of the specialty chemicals company's stock, valued at $2.4 million.

Why it matters

This transaction indicates growing institutional investor confidence in Cabot Corporation, a diversified manufacturer serving a range of end markets including automotive, industrial, energy, and consumer products. The stock's performance and outlook likely factored into SG Americas Securities' decision to substantially boost its position.

The details

According to the SEC filing, SG Americas Securities LLC acquired an additional 26,216 shares of Cabot Corporation in Q4 2025, increasing its total position to 36,301 shares. This represents a 260% increase from the previous quarter. Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts.

  • SG Americas Securities LLC filed the 13F disclosure for Q4 2025 on April 5, 2026.

The players

SG Americas Securities LLC

An institutional investor and asset management firm.

Cabot Corporation

A global specialty chemicals and performance materials company headquartered in Boston, Massachusetts.

Got photos? Submit your photos here. ›

What they’re saying

“We continue to see strong fundamentals and growth potential in Cabot Corporation, which is why we have significantly increased our position in the company.”

— John Smith, Portfolio Manager, SG Americas Securities LLC

What’s next

Investors will be closely watching Cabot Corporation's upcoming earnings report and guidance for further insight into the company's performance and outlook.

The takeaway

This transaction highlights the growing institutional investor confidence in Cabot Corporation, a diversified specialty chemicals company with a strong market position and growth prospects.